Atai Life Sciences (ATAI) Revenue & Revenue Breakdown
Atai Life Sciences Revenue Highlights
0
Latest Revenue (Q)
$1.55M
Main Segment (Y)
Research And Development Services
Atai Life Sciences Revenue by Period
Atai Life Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $314.00K | 34.76% |
| 2022-12-31 | $233.00K | -98.86% |
| 2021-12-31 | $20.38M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Atai Life Sciences generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Atai Life Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $1.55M | -31200.00% |
| 2024-12-31 | $-5.00K | -112.50% |
| 2024-09-30 | $40.00K | -85.35% |
| 2024-06-30 | $273.00K | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $18.00K | -79.31% |
| 2023-09-30 | $87.00K | -49.42% |
| 2023-06-30 | $172.00K | 364.86% |
| 2023-03-31 | $37.00K | -2.63% |
| 2022-12-31 | $38.00K | 58.33% |
| 2022-09-30 | $24.00K | -85.88% |
| 2022-06-30 | $170.00K | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $230.00K | -13.53% |
| 2021-09-30 | $266.00K | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $19.88M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Atai Life Sciences generated $1.55M in revenue during Q1 2025, up -31200.00% compared to the previous quarter, and up 8638.89% compared to the same period a year ago.
Atai Life Sciences Revenue Breakdown
Atai Life Sciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Research And Development Services | $300.00K | $300.00K | $200.00K | $600.00K |
Latest
Atai Life Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 24: Research And Development Services (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 22 | Sep 22 | Jun 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|
| License | - | $202.00K | - | - | - | - | - |
| Research And Development Services | - | - | - | $200.00K | $200.00K | $200.00K | $400.00K |
Latest
Atai Life Sciences Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jun 22 | Dec 21 | Sep 21 |
|---|---|---|---|
| Research And Development Services | $200.00K | $200.00K | $400.00K |
Latest
Atai Life Sciences's latest quarterly revenue breakdown by geography, as of Jun 22: Research And Development Services (100.00%).
Atai Life Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| WVE | Wave Life Sciences | $108.30M | $8.70M |
| AMLX | Amylyx Pharmaceuticals | $87.37M | - |
| IMTX | Immatics | $54.00M | $30.45M |
| SNDX | Syndax Pharmaceuticals | $23.68M | $37.96M |
| IMNM | Immunome | $9.04M | $2.93M |
| NUVB | Nuvation Bio | $7.87M | $4.83M |
| ATAI | Atai Life Sciences | - | $1.55M |
| ELVN | Enliven Therapeutics | - | - |
| PHVS | Pharvaris | - | - |
| SYRE | Spyre Therapeutics | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |